Related Experiment Video
Updated: May 20, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Ischemic stroke and patent foramen ovale: risk factors and genetic profile
Maria Lantz1, Christina Sjöstrand, Konstantinos Kostulas
1Department of Neurology, Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden. maria.lantz@karolinska.se
Insights
Patent foramen ovale (PFO) is linked to ischemic cerebrovascular disease (ICVD). Genetic analysis revealed a strong association between the F2 gene polymorphism and both PFO and ICVD in stroke patients.
Area of Science:
- Cardiovascular Genetics
- Neurology
- Stroke Research
Background:
- Patent foramen ovale (PFO) is a potential risk factor for ischemic cerebrovascular disease (ICVD), particularly in younger individuals.
- The precise role of PFO in the pathophysiology of ischemic stroke remains debated and requires further investigation.
- This study explored conventional risk factors and genetic polymorphisms associated with ICVD in patients with and without PFO.
Purpose of the Study:
- To investigate the association between genetic polymorphisms and ischemic cerebrovascular disease (ICVD) in patients with and without patent foramen ovale (PFO).
- To identify specific gene variants that may confer susceptibility to ICVD in the presence of PFO.
Main Methods:
- Genotyping of 100 polymorphisms in 47 suspected susceptibility genes was performed on 928 ICVD patients and 602 controls from the South Stockholm Ischemic Stroke Study.
- Stroke patients underwent comprehensive investigations, including standardized blood tests and, for a subset, transesophageal echocardiography to determine PFO status.
- Patients were categorized into groups based on the presence or absence of PFO.
Main Results:
- No significant differences in conventional risk factors or blood test results were observed between patients with and without PFO.
- Three polymorphisms in the prothrombin (F2) gene (20210G/A) and apolipoprotein-C3 (APO-CIII) genes (-641A/C and -455T/A) showed a significant association with ICVD and PFO.
- The F2 gene polymorphism exhibited the strongest association (P = .0049; odds ratio 26.4).
Conclusions:
- The prothrombin F2 gene polymorphism is significantly associated with both ICVD and PFO, supporting its potential role as a link between these conditions.
- A trend towards association was observed between two APO-CIII gene polymorphisms and the co-occurrence of PFO and ICVD.
- These genetic findings contribute to understanding the complex relationship between PFO and stroke risk.
Background:
Patent foramen ovale (PFO) is considered to be a risk factor for ischemic cerebrovascular disease (ICVD), especially in young people. However, the potential pathophysiological relevance in ischemic stroke is controversial and in need of further investigation. In this study, we examined the conventional risk factors and the distribution of 100 polymorphisms in 47 suspected susceptibility genes for ICVD in stroke patients with or without a PFO.
Methods:
In the South Stockholm Ischemic Stroke Study, 928 ICVD patients and 602 controls were genotyped for 100 different gene polymorphisms. The stroke patients also underwent relevant investigation and standardized blood tests. Patients who underwent transeosophageal echocardiography as part of their investigation were divided into groups that either had or did not have a PFO.
Results:
There were no significant differences in the 2 groups with regard to conventional risk factors or blood analyses. Three different polymorphisms located in the prothrombin, F2 (20210G/A), and apolipoprotein-C3 (-641A/C and -455T/A) genes were significantly associated with ICVD and PFO. The strongest association was found for F2 (P = .0049; odds ratio 26.4).
Conclusions:
We found that F2, which previously has been described as being a possible link between PFO and ICVD, was significantly associated with ICVD and PFO. There was also a trend toward an association between 2 other polymorphisms in the APO-CIII gene and PFO and ICVD.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction

